---
figid: PMC8909324__cancers-14-01196-g012
figtitle: Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling
  Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
organisms:
- Bos taurus
- Canis lupus familiaris
- Homo sapiens
organisms_ner:
- Bos taurus
- Homo sapiens
- Canis lupus familiaris
- Drosophila melanogaster
pmcid: PMC8909324
filename: cancers-14-01196-g012.jpg
figlink: /pmc/articles/PMC8909324/figure/cancers-14-01196-f012/
number: F12
caption: Biglycan interacts with IGF-IR to regulate osteosarcoma cells behavior. Biglycan
  binds to IGF-IR and activates the signaling cascade of the receptor. This complex
  formation stimulates the IGF-IR uptake to the cytoplasm, its sumoylation, and deposition
  to the nucleus where the receptor, putatively, acts as a transcriptional regulator
  or target genes. This mechanism involves biglycan in prolonged IGF-IR activation.
  The synergistic action of these molecules increases MG63 osteosarcoma cells aggressiveness,
  leading to enhanced growth and chemoresistance.
papertitle: Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling
  Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy.
reftext: Eirini-Maria Giatagana, et al. Cancers (Basel). 2022 Mar;14(5):1196.
year: '2022'
doi: 10.3390/cancers14051196
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: biglycan | insulin-like growth factor receptor I | extracellular matrix
  | osteosarcoma | chemoresistance
automl_pathway: 0.8954842
figid_alias: PMC8909324__F12
figtype: Figure
redirect_from: /figures/PMC8909324__F12
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8909324__cancers-14-01196-g012.html
  '@type': Dataset
  description: Biglycan interacts with IGF-IR to regulate osteosarcoma cells behavior.
    Biglycan binds to IGF-IR and activates the signaling cascade of the receptor.
    This complex formation stimulates the IGF-IR uptake to the cytoplasm, its sumoylation,
    and deposition to the nucleus where the receptor, putatively, acts as a transcriptional
    regulator or target genes. This mechanism involves biglycan in prolonged IGF-IR
    activation. The synergistic action of these molecules increases MG63 osteosarcoma
    cells aggressiveness, leading to enhanced growth and chemoresistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SUMO1
  - CS
  - DS
  - AKT1
  - PIK3CB
  - PTEN
  - IGF1R
  - PHGDH
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - KRAS
  - HRAS
  - NRAS
  - EPHB2
  - HNF4A
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - cs
  - ds
  - MKP-4
  - p38b
  - rl
  - ras
  - Ras64B
  - Ras85D
  - Erk7
  - Sumo
  - pan
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pten
---
